"10.1371_journal.pone.0023688","plos one","2011-08-29T00:00:00Z","Albert Y Liu; Eric Vittinghoff; Deborah E Sellmeyer; Risha Irvin; Kathleen Mulligan; Kenneth Mayer; Melanie Thompson; Robert Grant; Sonal Pathak; Brandon O'Hara; Roman Gvetadze; Kata Chillag; Lisa Grohskopf; Susan P Buchbinder","San Francisco Department of Public Health, San Francisco, California, United States of America; University of California San Francisco, San Francisco, California, United States of America; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Fenway Health, Boston, Massachusetts, United States of America; AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States of America; Gladstone Institutes, San Francisco, California, United States of America; Northrop Grumman, Atlanta, Georgia, United States of America; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America","Conceived and designed the experiments: AYL EV DES SPB. Performed the experiments: AYL K. Mulligan. Analyzed the data: AYL EV DES RI K. Mulligan K. Mayer MT RG SP BO ROG KC LG SPB. Contributed reagents/materials/analysis tools: EV. Wrote the paper: AYL EV DES RI K. Mulligan K. Mayer MT RG SP BO RG KC LG SPB.","Dr. Kenneth Mayer has received educational and research grants from Gilead Sciences, the pharmaceutical company that manufactures tenofovir. Dr. Melanie Thompsons organization (AIDS Research Consortium of Atlanta) has received research grant funding from Gilead and other pharmaceutical companies and has had a prevention research consultancy with Gilead Sciences. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","08","Albert Y Liu","AYL",14,TRUE,4,2,5,5,TRUE,TRUE,TRUE,6,"7;8;9;10;11;13",TRUE
